Moderna (MRNA) EV to CFO (2018 - 2026)
Moderna's (MRNA) quarterly EV to CFO came in at 43.35 in Q2 2026, down 611.27% year-over-year from 8.48 in Q2 2025, and down 82.54% quarter-over-quarter from 23.75 in Q1 2026.
Powered by 
Analysis
Moderna (MRNA) EV to CFO (2018 - 2026) Analysis & Trends
Moderna (MRNA) has reported EV to CFO for 9 consecutive years, with 43.35 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to CFO fell 611.27% year-over-year to 43.35 in Q2 2026; TTM through Jun 2026 was 21.25, a 923.26% decrease from a year earlier, with the FY2025 full-year figure at 3.11, down 3.43% from the prior year.
- EV to CFO was 43.35 for Q2 2026 at Moderna, down from 23.75 in the prior quarter.
- Over five years, EV to CFO peaked at 158.22 in Q2 2022 and troughed at 43.35 in Q2 2026.
- A 5-year average of 9.31 and a median of 6.35 in 2025 frame the typical range for EV to CFO.
- Across the five-year window, EV to CFO surged 641.42% in 2022 and plunged 611.27% in 2026, its largest moves.
- Over 5 years, EV to CFO stood at 35.65 in 2022, then jumped by 32.52% to 47.24 in 2023, then plunged by 76.85% to 10.94 in 2024, then tumbled by 42.79% to 6.26 in 2025, then sank by 792.76% to 43.35 in 2026.
- The last three EV to CFO figures came in at 43.35 (Q2 2026), 23.75 (Q1 2026), and 6.26 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Moderna | 72.66 Bn | 67.52 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.35 |
| Mar 31, 2026 | -23.75 |
| Dec 31, 2025 | 6.26 |
| Sep 30, 2025 | -6.61 |
| Jun 30, 2025 | -6.10 |
| Mar 31, 2025 | -4.82 |
| Dec 31, 2024 | 10.94 |
| Sep 30, 2024 | -12.05 |
| Jun 30, 2024 | -29.13 |
| Mar 31, 2024 | -32.65 |
| Dec 31, 2023 | 47.24 |
| Sep 30, 2023 | -19.86 |
| Jun 30, 2023 | -41.35 |
| Mar 31, 2023 | -40.86 |
| Dec 31, 2022 | 35.65 |
| Sep 30, 2022 | 148.47 |
| Jun 30, 2022 | 158.22 |
| Mar 31, 2022 | 21.28 |
| Dec 31, 2021 | 27.68 |
| Sep 30, 2021 | 44.86 |
API Access
Moderna EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();